A carregar...
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications
Despite chemotherapy and novel androgen-receptor signalling inhibitors (ARSi) have been approved during the last decades, metastatic castration-resistant prostate cancer (mCRPC) remains a lethal disease with poor clinical outcomes. Several studies found that germline or acquired DNA damage repair (D...
Na minha lista:
| Publicado no: | J Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492871/ https://ncbi.nlm.nih.gov/pubmed/32963528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4986365 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|